| Identification | Back Directory | [Name]
SHIKONIN(SH) | [CAS]
126105-12-2 | [Synonyms]
SHIKONIN(SH)
Momordica grosvenori(Luo Han Guo )
b-D-Glucopyranoside, (3b,9b,10a,11a,24R)-3-(b-D-glucopyranosyloxy)-11,25-dihydroxy-9-methyl-19-norlanost-5-en-24-ylO-b-D-glucopyranosyl-(12)-O-[b-D-glucopyranosyl-(16)]-
β-D-Glucopyranoside, (3β,9β,10α,11α,24R)-3-(β-D-glucopyranosyloxy)-11,25-dihydroxy-9-methyl-19-norlanost-5-en-24-yl O-β-D-glucopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→6)]-
(3beta,9beta,10alpha,11alpha,24R)-3-(beta-D-Glucopyranosyloxy)-11,25-dihydroxy-9-methyl-19-norlanost-5-en-24-yl O-beta-D-glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-6)]-beta-D-glucopyranoside | [Molecular Formula]
C54H92O24 | [MDL Number]
MFCD12546129 | [MOL File]
126105-12-2.mol | [Molecular Weight]
1125.29 |
| Hazard Information | Back Directory | [Chemical Properties]
White crystalline powder, soluble in water, insoluble in petroleum ether, dichloromethane, chloroform, benzene, ethyl acetate and other organic solvents, derived from Siraitia grosvenorii. | [Uses]
Used for content determination/identification/pharmacological experiments, etc. | [Biological Activity]
Siamenoside I is a mogroside and has an anti-cancer and antioxidant effect. | [in vivo]
In rat, the metabolic reactions of siamenoside I include deglycosylation, hydroxylation, dehydrogenation, deoxygenation, isomerization, and glycosylation. Siamenoside I and its metabolites are mainly distributed to the intestines, stomach, kidneys, and brain. p> |
|
|